Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
02/2014
02/13/2014US20140045846 Isoquinolin-1(2h)-one derivatives as parp-1 inhibitors
02/13/2014US20140045830 Cyclic urea- or lactam-substituted quinoxaline-type piperidine compounds and uses thereof
02/13/2014US20140045825 Inhibitors of PI3K-Delta and Methods of Their Use and Manufacture
02/13/2014US20140045823 N-cyclopropyl-n-piperidinyl-amides, pharmaceutical compositions containing them and uses thereof
02/13/2014US20140045822 Kinase inhibitors and method of treating cancer with same
02/13/2014US20140045815 Indazole-3-carboxamides and their use as wnt/beta-catenin signaling pathway inhibitors
02/13/2014US20140045813 Heteroaromatic compounds as btk inhibitors
02/13/2014US20140045802 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
02/13/2014US20140045790 Novel Bicyclic Pyridinones
02/13/2014US20140045746 Antidiabetic tricyclic compounds
02/12/2014EP2694619A1 Novel organic electroluminescent compounds and an organic electroluminescent device using the same
02/12/2014EP2694494A1 Fungicide hydroximoyl-tetrazole derivatives
02/12/2014EP2694493A1 Method for the preparation of process intermediates for the synthesis of argatroban monohydrate
02/12/2014EP2694492A1 Novel compounds as histamine h3 receptor ligands
02/12/2014EP2694484A1 Pyrimidine derivatives for the treatment of viral infections
02/12/2014EP2694483A1 Herbicidal compounds
02/12/2014EP2694482A1 Wnt pathway antagonists
02/12/2014EP2694480A1 Adamantyl compounds
02/12/2014EP2694479A1 Process for the preparation of an hiv integrase inhibitor
02/12/2014EP2694061A2 Compounds for use as therapeutic agents affecting p53 expression and/or activity
02/12/2014EP2694059A2 Small molecule inhibitors of xbp1 splicing
02/12/2014EP2693882A1 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
02/12/2014EP2693876A1 Substituted methylformyl reagents and method of using same to modify physicochemical and/or pharmacokinetic properties of compounds
02/12/2014CN1980917B Novel indole derivatives as selective androgen receptor modulators (SARMS)
02/12/2014CN103582637A Inhibitors of bruton's tyrosine kinase
02/12/2014CN103582636A (Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions containing them, and these compounds for use in treating proliferative diseases
02/12/2014CN103582633A Nitrogenated heterocyclic compound and agricultural or horticultural bactericidal agent
02/12/2014CN103582632A 取代的苯并咪唑 Substituted benzimidazoles
02/12/2014CN103582630A Neprilysin inhibitors
02/12/2014CN103582629A 5-(phenyl/pyridinyl-ethinyl)-2-pyridine/2-pyrimidine-carborxamides as MGLUR5 modulators
02/12/2014CN103571459A Aldehyde group functionalized pyridyl benzoimidazole fluorescent material and preparation method thereof
02/12/2014CN103570729A Bicyclic neonicotine compounds constructed by cycloalkenone, and preparation method and application thereof
02/12/2014CN103570696A Method for preparing intermediate of axitinib and application of intermediate in preparation of axitinib
02/12/2014CN103570693A Bridged compound serving as hepatitis C inhibitor and application of bridged compound in medicines
02/12/2014CN103570692A Quinazoline derivative with ethylene imine ring side chain as well as preparation and application
02/12/2014CN103570689A Para-nitro aromatic methyl crizotinib hypoxia-activated prodrug for anticancer drugs
02/12/2014CN103570688A 2,5-diaminomethylpyrazine compounds, drug compositions, preparation method and use thereof
02/12/2014CN103570687A Crystalline compound of omeprazole sodium
02/12/2014CN103570686A Method for synthesizing and refining esomeprazole sodium
02/12/2014CN103570685A Salt of 6,7-dimethoxyquinoline derivative
02/12/2014CN103570684A Phenylamine benzimidazole derivative and application of phenylamine benzimidazole derivative in preparation of anticoagulation medicine
02/12/2014CN103570683A Multi-substituted amine compound, as well as preparation method and use thereof
02/12/2014CN103570682A Preparation method of S-pantoprazole sodium
02/12/2014CN103570681A Prepration method of esomeprazole key intermediate
02/12/2014CN103570680A Dabigatran etexilate levulinic acid salt, preparation method and application thereof
02/12/2014CN103570679A Dabigatran etexilate gluconate, preparation method and application thereof
02/12/2014CN103570678A 2-quinolinone compound and preparation method and application thereof
02/12/2014CN103570677A Preparation method of alpha crystal form imatinib mesylate
02/12/2014CN103570676A Preparation of imatinib mesylate alpha crystal and pharmaceutical composition thereof
02/12/2014CN103570675A Salt of tetrahydroquinazolinone derivatives
02/12/2014CN103570674A Preparation method of imatinib mesylate alpha crystal form
02/12/2014CN103570673A Preparation method of imatinib mesylate alpha crystal form
02/12/2014CN103570630A Heterocyclic nitrogen derivative and application thereof in medicines
02/12/2014CN103570625A N-(3-aryl-heteroaryl)-4-aryl-aryl carboxamide and analog as hedgehog pathway inhibitors and application thereof
02/12/2014CN103570620A 1,12-iminobenzo[c]phenanthrene compound, intermediate, preparation method and application of compound
02/12/2014CN103012371B Omeprazole sodium crystalline compound, preparation method and medicine composition thereof
02/12/2014CN102791701B 3-(3-aminopiperidin-1-yl)-5-oxo-1,2,4-triazine derivates as dipeptidyl peptidase IV(DPP-IV) inhibitors
02/12/2014CN101573354B Substituted isoquinolines and their use as Rho-kinase inhibitors
02/11/2014US8648201 Aminopyridine derivatives for treating tumors and inflammatory diseases
02/11/2014US8648200 Imidazole derivatives useful for the treatment of arthritis
02/11/2014US8648199 Process for making a solid-state form of AMG 706
02/11/2014US8648197 Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists
02/11/2014US8648097 Pyridylaminoacetic acid compound
02/11/2014US8648096 N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same
02/11/2014US8648094 IAP BIR domain binding compounds
02/11/2014US8648088 Ethynyl nitrogen containing heteroaryl pyrazolidin-3-one derivatives
02/11/2014US8648087 N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
02/11/2014US8648072 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
02/11/2014US8648069 5-substituted indazoles as kinase inhibitors
02/11/2014US8648067 Substituted phenoxypropylcycloamine derivatives as histamine-3 (H3) receptor ligands
02/11/2014CA2792950C 5-(optionally substituted phenyl) pyridin-2-yl compounds as metalloenzyme inhibitors
02/11/2014CA2738563C 8-substituted isoquinoline derivatives and the use thereof
02/11/2014CA2650954C Bicyclic derivatives as cetp inhibitors
02/11/2014CA2646678C Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
02/11/2014CA2511199C Small molecule modulators of hepatocyte growth factor (scatter factor) activity
02/06/2014WO2014022767A1 Dihydropyridone p1 as factor xia inhibitors
02/06/2014WO2014022766A1 Dihydropyridone p1 as factor xia inhibitors
02/06/2014WO2014022728A1 Substituted 5 - (quinazolin - 2 - yl) pyrimidin- 2 -amine derivatives useful as pi3k/mtor inhibitors for the treatment of cancer
02/06/2014WO2014022660A1 Curcumin analogs and methods of making and using thereof
02/06/2014WO2014022528A1 Antidiabetic tricyclic compounds
02/06/2014WO2014022343A1 7-hydroxy-indolinyl antagonists of p2y1 receptor
02/06/2014WO2014022128A1 Pi3 kinase modulators and methods of use
02/06/2014WO2014022116A2 Substituted pyrazolone compounds and methods of use
02/06/2014WO2014021652A1 Anhydrous aripiprazole crystals and production method for same
02/06/2014WO2014021281A1 Partially saturated nitrogen-containing heterocyclic compound
02/06/2014WO2014020546A2 Crystalline forms of dabigatran etexilate and process for their preparation
02/06/2014WO2014020467A2 Process for the preparation of pyrazole substituted aminoheteroaryl compounds
02/06/2014WO2014020264A1 Novel iron complexes capable of detecting a nitro-reducing chemical or biochemical entity, in particular by in vivo mri, and in vitro detection method
02/06/2014WO2014019967A1 N-cyclopropyl-n-piperidinyl-amides, pharmaceutical compositions containing them and uses thereof
02/06/2014WO2014019908A2 Substituted pyrroles active as kinases inhibitors
02/06/2014WO2014019344A1 Bridged ring compounds as hepatitis c virus (hcv) inhibitors and pharmaceutical applications thereof
02/06/2014WO2013182451A9 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
02/06/2014US20140039012 Compounds Having CRTH2 Antagonist Activity
02/06/2014US20140039001 Novel salts of 6-heterocycle substituted hexahydrophenanthridine derivatives
02/06/2014US20140038995 Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor
02/06/2014US20140038994 Salts of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
02/06/2014US20140038993 New compounds
02/06/2014US20140038987 SUBSTITUTED 1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
02/06/2014US20140038986 Markers associated with human double minute 2 inhibitors
02/06/2014US20140038979 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 1080